Benefits for Treating Alzheimer's Disease - Slows Onset of Confusion
Depression and Aggression Over 24 Month Period
July 19th 2006
Researchers have demonstrated Flurizan can help patients with
Alzheimer’s disease. Flurizan, made by Myriad Genetics, when given in
the larger doses (800 milligram twice a day) can slow the cognitive
decline caused by Alzheimer ’s disease.
In this study, the groups taking the higher doses demonstrated a
substantial benefit over other dose groups in the study and that this
benefit continued over 24 months. The testing included memory loss,
cognition and global function.
This is considered a small mid-state trial, but the results are
promising. Adrian Hobden, Ph.D., President of Myriad Pharmaceuticals,
Inc. said "The 24 month data completes the Phase 2 follow-on trial with
mounting evidence of efficacy against mild Alzheimer's disease that
consistently increased over the course of the study. The results are
consistent with a mode of action for Flurizan that is modifying the
course of the underlying disease process."